Bob Herman and Rachel Cohrs Zhang

BioTech

Medicare expects to spend $3.5 billion on new Alzheimer’s drug in 2025

Medicare for the first time has estimated that a new Alzheimer’s treatment could cost the program billions of dollars by next year — well beyond

Bob Herman and Rachel Cohrs Zhang April 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Bob Herman and Rachel Cohrs Zhang

Medicare expects to spend $3.5 billion on new Alzheimer’s drug in 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe